Berndt Modig, Chief Executive Officer and Director of Pharvaris N.V. (NASDAQ:PHVS), filed a Form 4 on September 16, 2026, reporting the sale of 2,291 shares of common stock on September 14, 2026, pursuant to a Rule 10b5-1 trading plan.

Key Highlights

  • Shares sold: 2,291 shares of common stock were disposed of on September 14, 2026, with transaction code "S."
  • Weighted average price: The shares sold at a weighted average price of $39.4046, with individual transaction prices ranging from $38.69 to $40.39.
  • Source of shares: According to the filing, the shares were acquired upon vesting of restricted stock units and sold in connection with a cashless exercise of stock options.
  • Direct ownership following transaction: Modig directly holds 128,334 shares of common stock after the reported transaction.
  • Indirect ownership: Modig indirectly holds 950,000 shares through Schoodic Management BV, an entity the filing states is controlled by Mr. Modig.
  • 10b5-1 plan: The filing indicates the transaction was made pursuant to a Rule 10b5-1 trading plan.

Pharvaris CEO Modig Reports RSU Vesting Sale and Post-Transaction Ownership

According to the Form 4 filed with the U.S. Securities and Exchange Commission, Berndt Modig, serving as both Chief Executive Officer and Director of Pharvaris N.V., disposed of 2,291 shares of common stock on September 14, 2026. The filing states the shares were acquired upon vesting of restricted stock units and sold pursuant to a Rule 10b5-1 trading plan, in connection with a cashless exercise of stock options.

The filing reports that the sale was executed across multiple transactions on the same date at a weighted average price of $39.4046 per share. Individual transaction prices ranged from $38.69 to $40.39. The filing notes that Modig "undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."

Following the reported transaction, the filing discloses that Modig directly holds 128,334 shares of common stock. In addition, 950,000 shares are held indirectly through Schoodic Management BV, described in the filing as an entity controlled by Mr. Modig. The Form 4 was signed by Marnus Nel as Attorney-in-Fact for Berndt Modig and filed on September 16, 2026.

What Was Disclosed

Pharvaris N.V. CEO Berndt Modig reported the sale of 2,291 common shares on September 14, 2026, at a weighted average price of $39.4046, under a Rule 10b5-1 plan. Post-transaction, he directly holds 128,334 shares and indirectly holds 950,000 shares via Schoodic Management BV.